Skip to main content
Caplight Logo









BioArmix

BioArmix

Private
IsraelCrypto & Web3https://www.bioarmix.com/

Last Round

Grant

Oct 16, 2025

Total Funding Raised

$23,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BioArmix is an agricultural chemicals company that manufactures natural biocontrol agents intended to protect crops from bacterial diseases.

Sector

Crypto & Web3

Verticals

Blockchain Infrastructure, Biotechnology, Data Governance, Digital Wallets

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

biocontrol agentbiopesticidepredatory bacteriacrop protectionagricultural biotechagritechagtechbiological crop protectionmicrobial pesticidebiocontrolsustainable agricultureag bioencapsulated bacteriapowder formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioArmix Comparables

Compare BioArmix with similar companies based on industry and business-model similarity.

BioArmix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EcoPhage
34%

BioArmix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 16, 2025
Pre SeedJan 1, 2024

Key People

Founding team and executive leadership

Tzvi Zvirin

Co-Founder & CEO

Founding Team

BioArmix Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 16, 2025

    $23K grant received from EIT Food Accelerator Network.

  • Jan 1, 2024

    Secured Pre Seed funding from Galil Ofek Innovation and others.

BioArmix Filings

Explore SEC and related filing metadata, where available.

BioArmix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioArmix's valuation, stock price, and market status.

Is BioArmix a public or private company?

BioArmix is a private company.

What is the current stock price of BioArmix?

BioArmix is a private company with no public stock price. No recent secondary market data is available.

How much is BioArmix worth (valuation)?

Valuation information for BioArmix is not publicly available.

Can I buy BioArmix stock?

BioArmix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioArmix's last funding round?

BioArmix's most recent funding round was Grant on October 16, 2025.

Who are the main investors in BioArmix?

Key investors in BioArmix include Biotope by VIB, Galil Ofek Innovation, Yissum Research Development Company of the Hebrew University of Jerusalem, EIT Food Accelerator Network.

Will BioArmix IPO soon?

No public IPO plans have been announced for BioArmix.

How can I track BioArmix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioArmix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range4
Year Founded2023
Last FundingOct 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?